Multicenter nonrandomized trial of ramosetron versus palonosetron in controlling chemotherapy-induced nausea and vomiting for colorectal cancer

PURPOSE: Chemotherapy-induced nausea and vomiting (CINV) have a negative impact on patients' quality of life and frequently pointed to as a major factor for treatment abandonment. Serotonin (5-HT(3)) receptor antagonist is considered as key treatment for CINV. Ramosetron and palonosetron are re...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Kim, Jin Soo, Kim, Ji Yeon, Lee, Sang-Jeon, Park, Dong Kook, Namgung, Hwan, Kim, Chang Nam, Choi, Won Jun, Baek, Moo Jun
Format: Artigo
Idioma:Inglês
Publicat: The Korean Surgical Society 2014
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4091445/
https://ncbi.nlm.nih.gov/pubmed/25025021
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4174/astr.2014.87.1.9
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars